möglich sobald bei der ZB eingereicht worden ist.
Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy.
Nat. Cancer 4, 454-467 (2023)
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer entity characterized by a heterogeneous genetic landscape and an immunosuppressive tumor microenvironment. Recent advances in high-resolution single-cell sequencing and spatial transcriptomics technologies have enabled an in-depth characterization of both malignant and host cell types and increased our understanding of the heterogeneity and plasticity of PDAC in the steady state and under therapeutic perturbation. In this Review we outline single-cell analyses in PDAC, discuss their implications on our understanding of the disease and present future perspectives of multimodal approaches to elucidate its biology and response to therapy at the single-cell level.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Ductal Adenocarcinoma; Fibroblasts; Tumor; Rna; Immunosuppression; Subtypes; Microenvironment; Inhibition; Genomics; Seq
ISSN (print) / ISBN
2662-1347
e-ISSN
2662-1347
Zeitschrift
Nature Cancer
Quellenangaben
Band: 4,
Heft: 4,
Seiten: 454-467
Verlag
Springer
Verlagsort
Heidelberger Platz 3, Berlin, 14197, Germany
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Computational Biology (ICB)
Förderungen
Deutsche Forschungsgemeinschaft
German Cancer Consortium
Wilhelm Sander-Stiftung
European Research Council (ERC CoG )
Cancer Research Institute
German Cancer Consortium
Wilhelm Sander-Stiftung
European Research Council (ERC CoG )
Cancer Research Institute